120.51
price down icon3.00%   -3.73
after-market After Hours: 118.34 -2.17 -1.80%
loading

Glaukos Corporation Stock (GKOS) Latest News

pulisher
06:08 AM

GLAUKOS Corp SEC 10-K Report - TradingView

06:08 AM
pulisher
Feb 24, 2025

FDA sets review date for Glaukos' keratoconus drug By Investing.com - Investing.com Australia

Feb 24, 2025
pulisher
Feb 24, 2025

FDA sets review date for Glaukos’ keratoconus drug By Investing.com - Investing.com Nigeria

Feb 24, 2025
pulisher
Feb 24, 2025

GKOSGlaukos Corp Latest Stock News & Market Updates - StockTitan

Feb 24, 2025
pulisher
Feb 24, 2025

FDA accepts Glaukos application for Epioxa for keratoconus - MSN

Feb 24, 2025
pulisher
Feb 24, 2025

Here's How Much $100 Invested In Glaukos 5 Years Ago Would Be Worth Today - Benzinga

Feb 24, 2025
pulisher
Feb 24, 2025

FDA Sets Decision Date For Glaukos' Keratoconus Treatment Without The Need Of Surgery - Benzinga

Feb 24, 2025
pulisher
Feb 24, 2025

Glaukos Announces FDA Acceptance of NDA Submission for Epioxa™ - BioSpace

Feb 24, 2025
pulisher
Feb 24, 2025

Glaukos's Corneal Disease Drug Accepted for FDA Review -February 24, 2025 at 07:33 am EST - Marketscreener.com

Feb 24, 2025
pulisher
Feb 24, 2025

FDA sets review date for Glaukos' keratoconus drug - Investing.com

Feb 24, 2025
pulisher
Feb 24, 2025

Revolutionary Eye Treatment Advances: Can Glaukos Transform Keratoconus Care Without Surgery? - StockTitan

Feb 24, 2025
pulisher
Feb 24, 2025

Van ECK Associates Corp Trims Position in Glaukos Co. (NYSE:GKOS) - Defense World

Feb 24, 2025
pulisher
Feb 24, 2025

Glaukos (NYSE:GKOS) Price Target Raised to $160.00 - Defense World

Feb 24, 2025
pulisher
Feb 23, 2025

Glaukos (GKOS) Reports Q4 Loss, Tops Revenue Estimates - MSN

Feb 23, 2025
pulisher
Feb 22, 2025

Glaukos Corporation (NYSE:GKOS) Yearly Results Just Came Out: Here's What Analysts Are Forecasting For This Year - Simply Wall St

Feb 22, 2025
pulisher
Feb 22, 2025

Glaukos Reports Record Sales Growth in Fourth Quarter of 2024, Announces 2025 Guidance - Vision Monday

Feb 22, 2025
pulisher
Feb 21, 2025

Glaukos Q4 2024 Earnings Preview - MSN

Feb 21, 2025
pulisher
Feb 21, 2025

Glaukos Corp. Reports Record Sales in Earnings Call - TipRanks

Feb 21, 2025
pulisher
Feb 21, 2025

Truist maintains buy on Glaukos stock, price target steady at $185 - Investing.com Australia

Feb 21, 2025
pulisher
Feb 21, 2025

Glaukos Corp earnings missed by $0.02, revenue topped estimates - Investing.com Australia

Feb 21, 2025
pulisher
Feb 21, 2025

Earnings call transcript: Glaukos Corp Q4 2024 sees revenue rise but EPS miss - Investing.com Nigeria

Feb 21, 2025
pulisher
Feb 21, 2025

Truist maintains buy on Glaukos stock, price target steady at $185 By Investing.com - Investing.com South Africa

Feb 21, 2025
pulisher
Feb 21, 2025

GKOS Stock Falls Despite Q4 Earnings & Revenue Beat, Margins Decline - MSN

Feb 21, 2025
pulisher
Feb 21, 2025

Glaukos Delivers Mixed Q4 Results, Analyst Sees Growing Investor Interest During Transition - Benzinga

Feb 21, 2025
pulisher
Feb 21, 2025

BTIG cuts Glaukos stock price target to $155 from $157 By Investing.com - Investing.com Nigeria

Feb 21, 2025
pulisher
Feb 21, 2025

Glaukos Corporation (NYSE:GKOS) Q4 2024 Earnings Call Transcript - Insider Monkey

Feb 21, 2025
pulisher
Feb 21, 2025

Glaukos Corp Q4 2024 Earnings: Revenue Surpasses Estimates at $1 - GuruFocus.com

Feb 21, 2025
pulisher
Feb 21, 2025

Glaukos price target raised to $160 from $153 at Wells Fargo - TipRanks

Feb 21, 2025
pulisher
Feb 21, 2025

BTIG cuts Glaukos stock price target to $155 from $157 - Investing.com

Feb 21, 2025
pulisher
Feb 21, 2025

Glaukos Corp (GKOS) Q4 2024 Earnings Call Highlights: Record Sales and Strategic Growth Amid ... - Yahoo Finance

Feb 21, 2025
pulisher
Feb 21, 2025

Glaukos Announces Fourth Quarter and Full Year 2024 Financial Results - BioSpace

Feb 21, 2025
pulisher
Feb 21, 2025

Glaukos: Q4 Earnings Snapshot - Danbury News Times

Feb 21, 2025
pulisher
Feb 20, 2025

Glaukos Corporation Reports Strong 2024 Financial Results - TipRanks

Feb 20, 2025
pulisher
Feb 20, 2025

Insider Selling: Glaukos Co. (NYSE:GKOS) Insider Sells 3,416 Shares of Stock - MarketBeat

Feb 20, 2025
pulisher
Feb 20, 2025

Why Glaukos Stock is Soaring: Key Insights - TipRanks

Feb 20, 2025
pulisher
Feb 20, 2025

Glaukos Corp reports results for the quarter ended December 31Earnings Summary - TradingView

Feb 20, 2025
pulisher
Feb 20, 2025

Glaukos shares tumble 12% on wider-than-feared Q4 loss - Investing.com

Feb 20, 2025
pulisher
Feb 20, 2025

Glaukos shares tumble 12% on wider-than-feared Q4 loss By Investing.com - Investing.com Australia

Feb 20, 2025
pulisher
Feb 20, 2025

Glaukos Q4 Non-GAAP Loss Narrows, Sales Rise -February 20, 2025 at 04:37 pm EST - Marketscreener.com

Feb 20, 2025
pulisher
Feb 20, 2025

Glaukos: Q4 Earnings Snapshot -February 20, 2025 at 05:52 pm EST - Marketscreener.com

Feb 20, 2025
pulisher
Feb 20, 2025

Glaukos Reports Record Sales and Positive Revenue Outlook - TipRanks

Feb 20, 2025
pulisher
Feb 20, 2025

Earnings Flash (GKOS) GLAUKOS CORPORATION Posts Q4 Loss $-0.40 Per Share, vs. FactSet Est of $-0.38 - Marketscreener.com

Feb 20, 2025
pulisher
Feb 20, 2025

What To Expect From Glaukos Corp (GKOS) Q4 2024 Earnings - Yahoo Finance

Feb 20, 2025
pulisher
Feb 20, 2025

Glaukos (NYSE:GKOS) Upgraded by Mizuho to Outperform Rating - MarketBeat

Feb 20, 2025
pulisher
Feb 20, 2025

Glaukos Co. (NYSE:GKOS) Stock Holdings Trimmed by New York State Common Retirement Fund - MarketBeat

Feb 20, 2025
pulisher
Feb 20, 2025

Glaukos Co. (NYSE:GKOS) Shares Sold by Peregrine Capital Management LLC - MarketBeat

Feb 20, 2025
pulisher
Feb 19, 2025

Glaukos chief development officer Navratil sells $502,630 in stock - Investing.com

Feb 19, 2025
pulisher
Feb 19, 2025

Glaukos chief development officer Navratil sells $502,630 in stock By Investing.com - Investing.com South Africa

Feb 19, 2025
pulisher
Feb 19, 2025

Glaukos Stock Soars on Promising iDose Outlook - TipRanks

Feb 19, 2025
pulisher
Feb 19, 2025

Mizuho Upgrades Glaukos (GKOS) - Nasdaq

Feb 19, 2025
pulisher
Feb 19, 2025

This NetApp Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Wednesday - Benzinga

Feb 19, 2025
medical_devices ZBH
$107.35
price up icon 1.29%
medical_devices STE
$223.79
price up icon 0.05%
medical_devices PHG
$26.73
price up icon 2.89%
$88.32
price down icon 2.68%
$90.81
price up icon 0.26%
medical_devices EW
$71.45
price down icon 1.80%
Cap:     |  Volume (24h):